BlackRock Health Sciences... (BME)
NYSE: BME
· Real-Time Price · USD
44.86
+0.46 (1.04%)
At close: Aug 18, 2026, 3:59 PM
BlackRock Health Sciences Trust (BME) Stock Price, Analysis & Data
1.04% (1D)
| Bid | n/a |
| Market Cap | 579.78M |
| Revenue (ttm) | 7.74M |
| Net Income (ttm) | 76.97M |
| Beta | 0.58 |
| EPS (ttm) | 5.92 |
| PE Ratio (ttm) | 7.58 |
| Forward PE | n/a |
| P/B (ttm) | 1.02 |
| P/S (ttm) | 74.95 |
| Earnings Date | n/a |
| Ask | n/a |
| Volume | 34,978 |
| Avg. Volume (20D) | 45,465 |
| Open | 44.64 |
| Previous Close | 44.40 |
| Day's Range | 44.50 - 44.96 |
| 52-Week Range | 35.95 - 44.99 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | $3.15 (7.08%) |
| Ex-Dividend Date | Sep 15, 2026 |
About BME
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical ...
Industry Asset Management
Sector Financial Services
IPO Date Mar 29, 2005
Employees n/a
Stock Exchange NYSE
Ticker Symbol BME
Financial Performance
In 2025, BlackRock Health Sciences Trust's revenue was 77.54M, an increase of 222.1% compared to the previous year's 24.07M. Earnings were 76.97M, an increase of 228.16%.
Financial Statements
